Bellevue Group AG boosted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 18.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,507,731 shares of the company’s stock after buying an additional 382,531 shares during the quarter. Arvinas […]
Arvinas, Inc. (NASDAQ:ARVN – Get Free Report) was down 10.3% on Monday . The company traded as low as $29.72 and last traded at $29.72. Approximately 456,905 shares changed hands during trading, a decline of 36% from the average daily volume of 719,479 shares. The stock had previously closed at $33.14. Wall Street Analyst Weigh […]
NEW HAVEN, Conn., June 03, 2024 Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will.
Arvinas to Participate in Upcoming Investor Conferences tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
3 Of My Favorite Names On Wells Fargo's Biotech Buyout List seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.